Cutaneous ureterostomy in cancer patients.
Twenty-four patients with malignant pelvic mass had diverting ureterocutaneostomy. Four patients (17%) developed necrosis and one (4%) required surgical correction due to stenosis. The remaining patients had a well-functioning ureterocutaneostomy until the death which occurred median 174 days later. We find that good palliation can be achieved using this simple operation, and therefore recommend it as the urinary diverting procedure to patients with obstructing pelvic malignancy.